DNA	Gene	Variant	P	SD	Comments
c.1036C>T	BRCA1	p.(Pro346Ser)	0.006191	0.013847	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.1075C>T	BRCA1	p.(Pro359Ser)	0.000196	0.000171	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.1081T>C	BRCA1	p.(Ser361Pro)	0.000043	0.000043	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.1310A>T	BRCA1	p.(His437Leu)	0.000099	0.000093	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.131G>T	BRCA1	p.(Cys44Phe)	0.998233	0.001656	Predicted pathogenic = 1.HGMD-assigned category: DM; 2.Interpro conserved site (dbnsfp): True; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.1342C>T	BRCA1	p.(His448Tyr)	0.006616	0.008274	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.134A>C	BRCA1	p.(Lys45Thr)	0.138456	0.137547	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.GERP++NR and GERP++RS difference (dbnsfp); 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.Regulatory Constraint Score (skippy); 7.Exon Normalized per Transcript (snpeff); 8.Amino Acid Length (snpeff)
c.1361G>A	BRCA1	p.(Ser454Asn)	0.000097	0.000080	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.1383T>A	BRCA1	p.(Phe461Leu)	0.036787	0.021645	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Min Distance from a SS (skippy); 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.1396C>T	BRCA1	p.(Arg466Trp)	0.000907	0.000534	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.140G>A	BRCA1	p.(Cys47Tyr)	0.991751	0.007750	Predicted pathogenic = 1.HGMD-assigned category: DM; 2.Interpro conserved site (dbnsfp): True; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.1418A>T	BRCA1	p.(Asn473Ile)	0.000233	0.000211	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Mean hSNP Regulatory Constraint Score (skippy); 5.SIFT prediction (dbnsfp): Damaging; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.1423A>T	BRCA1	p.(Ser475Cys)	0.034244	0.024787	Predicted benign = 1.Exon Length (skippy); 2.LRT prediction (dbnsfp): Neutral; 3.Min Distance from a SS (skippy); 4.Exon Type (skippy): internal_exon_protein_coding; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Mean hSNP Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.1508A>G	BRCA1	p.(Lys503Arg)	0.002923	0.002609	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.1514A>T	BRCA1	p.(Lys505Ile)	0.100969	0.060815	Predicted benign = 1.Exon Length (skippy); 2.Min Distance from a SS (skippy); 3.Exon Type (skippy): internal_exon_protein_coding; 4.ESE Losses (skippy); 5.Mean hSNP Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Gene: BRCA1; 8.Amino Acid Length (snpeff)
c.1534C>T	BRCA1	p.(Leu512Phe)	0.012416	0.013280	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.154C>A	BRCA1	p.(Leu52Ile)	0.753689	0.156710	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 3.phastCons100way vertebrate (dbnsfp); 4.LRT prediction (dbnsfp): Deleterious; 5.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 6.Exon Length (skippy); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.1601A>G	BRCA1	p.(Gln534Arg)	0.000258	0.000257	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.1703C>G	BRCA1	p.(Pro568Arg)	0.004780	0.006609	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.172C>G	BRCA1	p.(Pro58Ala)	0.761314	0.169072	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has one or more PUBMEDs curated by HGMD: True; 3.HGMD-assigned category: DM; 4.Has an entry in HGMD: True; 5.Associated with cancer by HGMD: True; 6.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 7.phastCons100way vertebrate (dbnsfp); 8.Exon Length (skippy)
c.1756C>T	BRCA1	p.(Pro586Ser)	0.000286	0.000272	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Min Distance from a SS (skippy); 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.1772T>C	BRCA1	p.(Ile591Thr)	0.000015	0.000025	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.1834A>G	BRCA1	p.(Arg612Gly)	0.000039	0.000060	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.1846_1848del	BRCA1	p.(Ser616del)	0.002896	0.010668	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.01% to 0.1%; 3.phastCons100way vertebrate (dbnsfp); 4.Gene: BRCA1; 5.Amino Acid Length (snpeff); 6.Latino allele frequency (gnomad); 7.All allele frequency (gnomad); 8.South Asian allele frequency (gnomad)
c.1879G>A	BRCA1	p.(Val627Ile)	0.000056	0.000085	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.1903A>G	BRCA1	p.(Asn635Asp)	0.000142	0.000196	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.1927A>G	BRCA1	p.(Ser643Gly)	0.059720	0.058925	Predicted benign = 1.Exon Length (skippy); 2.Min Distance from a SS (skippy); 3.Exon Type (skippy): internal_exon_protein_coding; 4.SIFT prediction (dbnsfp): Damaging; 5.Regulatory Constraint Score (skippy); 6.Gene: BRCA1; 7.Polyphen2 HVAR prediction (dbnsfp): Possibly damaging; 8.Amino Acid Length (snpeff)
c.2006T>C	BRCA1	p.(Met669Thr)	0.000198	0.000280	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.2042G>T	BRCA1	p.(Ser681Ile)	0.002231	0.004099	Predicted benign = 1.Exon Length (skippy); 2.Min Distance from a SS (skippy); 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2050C>T	BRCA1	p.(Pro684Ser)	0.000856	0.001189	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.2060A>C	BRCA1	p.(Gln687Pro)	0.001392	0.001891	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2083G>T	BRCA1	p.(Asp695Tyr)	0.000161	0.000207	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.211A>G	BRCA1	p.(Arg71Gly)	0.984843	0.010976	Predicted pathogenic = 1.HGMD-assigned category: DM; 2.Has an entry in HGMD: True; 3.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 4.Mean hSNP Regulatory Constraint Score (skippy); 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.2180C>T	BRCA1	p.(Pro727Leu)	0.000002	0.000002	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Allele Frequency Group (linear scale): 0.0% to 0.005%; 8.Amino Acid Length (snpeff)
c.2183G>A	BRCA1	p.(Arg728Lys)	0.000006	0.000008	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.2245G>T	BRCA1	p.(Asp749Tyr)	0.001367	0.002235	Predicted benign = 1.Exon Length (skippy); 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2338C>A	BRCA1	p.(Gln780Lys)	0.052156	0.055441	Predicted benign = 1.Exon Length (skippy); 2.Min Distance from a SS (skippy); 3.Exon Type (skippy): internal_exon_protein_coding; 4.ESE Losses (skippy); 5.Mean hSNP Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Gene: BRCA1; 8.Amino Acid Length (snpeff)
c.2346T>A	BRCA1	p.(Ser782Arg)	0.013412	0.021348	Predicted benign = 1.Exon Length (skippy); 2.Min Distance from a SS (skippy); 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.GERP++NR and GERP++RS difference (dbnsfp); 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.2351C>T	BRCA1	p.(Ser784Leu)	0.002352	0.005032	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Exon Length (skippy); 3.Has sample(s) where the variant co-occurred with a known P/LP: True; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.2447A>G	BRCA1	p.(His816Arg)	0.000049	0.000152	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.2452T>G	BRCA1	p.(Cys818Gly)	0.000087	0.000122	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.2482G>A	BRCA1	p.(Gly828Ser)	0.000091	0.000145	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.2503C>T	BRCA1	p.(His835Tyr)	0.000008	0.000016	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.2518A>T	BRCA1	p.(Ser840Cys)	0.000179	0.000255	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2522G>A	BRCA1	p.(Arg841Gln)	0.000021	0.000040	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.2597G>A	BRCA1	p.(Arg866His)	0.001346	0.001768	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.2650A>G	BRCA1	p.(Thr884Ala)	0.000110	0.000205	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.2662C>T	BRCA1	p.(His888Tyr)	0.000086	0.000153	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.2668G>C	BRCA1	p.(Gly890Arg)	0.000011	0.000016	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.2692A>G	BRCA1	p.(Lys898Glu)	0.000641	0.001262	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.2728C>G	BRCA1	p.(Gln910Glu)	0.000216	0.000336	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.2758G>A	BRCA1	p.(Val920Ile)	0.000003	0.000004	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2765C>G	BRCA1	p.(Thr922Arg)	0.001174	0.001618	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.2783G>A	BRCA1	p.(Gly928Asp)	0.000072	0.000115	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Mean hSNP Regulatory Constraint Score (skippy); 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.2798G>C	BRCA1	p.(Gly933Ala)	0.000458	0.000565	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2857T>C	BRCA1	p.(Cys953Arg)	0.000502	0.000531	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2884G>A	BRCA1	p.(Glu962Lys)	0.000008	0.000015	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.2912A>G	BRCA1	p.(His971Arg)	0.000118	0.000136	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.2917C>G	BRCA1	p.(Leu973Val)	0.000118	0.000136	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.2935C>T	BRCA1	p.(Arg979Cys)	0.000033	0.000059	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.2963C>T	BRCA1	p.(Ser988Leu)	0.000296	0.000476	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.2998_3003del	BRCA1	p.(Glu1000_Glu1001del)	0.037514	0.022815	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Allele Frequency Group (linear scale): 0.0% to 0.005%; 4.phastCons100way vertebrate (dbnsfp); 5.Gene: BRCA1; 6.Amino Acid Length (snpeff); 7.Homopolymer Length; 8.All allele frequency (gnomad)
c.2998G>A	BRCA1	p.(Glu1000Lys)	0.000512	0.000540	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.3040A>T	BRCA1	p.(Met1014Leu)	0.000000	0.000001	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.305C>G	BRCA1	p.(Ala102Gly)	0.105840	0.070166	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.Regulatory Constraint Score (skippy); 5.Exon Normalized per Transcript (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.Log Odds Ratio Total (skippy)
c.3082C>T	BRCA1	p.(Arg1028Cys)	0.006020	0.013175	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3143G>A	BRCA1	p.(Gly1048Asp)	0.000008	0.000013	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3143G>T	BRCA1	p.(Gly1048Val)	0.000124	0.000147	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.SIFT prediction (dbnsfp): Tolerated; 4.Mean hSNP Regulatory Constraint Score (skippy); 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.3211G>A	BRCA1	p.(Glu1071Lys)	0.000213	0.000201	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.3220A>G	BRCA1	p.(Arg1074Gly)	0.000031	0.000031	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.3267G>T	BRCA1	p.(Leu1089Phe)	0.000315	0.000310	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.Mean hSNP Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.3280T>G	BRCA1	p.(Tyr1094Asp)	0.000423	0.000379	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.3305A>G	BRCA1	p.(Asn1102Ser)	0.000080	0.000075	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.3416G>T	BRCA1	p.(Ser1139Ile)	0.000002	0.000002	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3424G>C	BRCA1	p.(Ala1142Pro)	0.000074	0.000068	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.Mean hSNP Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.3425C>T	BRCA1	p.(Ala1142Val)	0.000121	0.000103	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.3454G>A	BRCA1	p.(Asp1152Asn)	0.000031	0.000031	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3541G>A	BRCA1	p.(Val1181Ile)	0.000002	0.000002	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3581C>T	BRCA1	p.(Thr1194Ile)	0.000401	0.000296	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.3596C>T	BRCA1	p.(Ala1199Val)	0.000051	0.000051	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3622A>G	BRCA1	p.(Lys1208Glu)	0.002187	0.001676	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.Min Distance from a SS (skippy); 7.Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.3655G>A	BRCA1	p.(Glu1219Lys)	0.076949	0.045909	Predicted benign = 1.Exon Length (skippy); 2.Exon Type (skippy): internal_exon_protein_coding; 3.Allele Frequency Group (linear scale): 0.0% to 0.005%; 4.Min Distance from a SS (skippy); 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Regulatory Constraint Score (skippy)
c.3657G>C	BRCA1	p.(Glu1219Asp)	0.065925	0.055319	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.3667C>T	BRCA1	p.(Leu1223Phe)	0.241411	0.115637	Predicted benign = 1.Exon Length (skippy); 2.ESE Losses (skippy); 3.Exon Type (skippy): internal_exon_protein_coding; 4.Min Distance from a SS (skippy); 5.Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Gene: BRCA1; 8.Amino Acid Length (snpeff)
c.3708T>G	BRCA1	p.(Asn1236Lys)	0.000014	0.000019	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.3724A>G	BRCA1	p.(Thr1242Ala)	0.000108	0.000086	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.3848A>G	BRCA1	p.(His1283Arg)	0.000133	0.000116	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3902G>A	BRCA1	p.(Ser1301Asn)	0.000310	0.000223	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Allele Frequency Group (linear scale): 0.0% to 0.005%; 8.Amino Acid Length (snpeff)
c.397C>T	BRCA1	p.(Arg133Cys)	0.132516	0.057224	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Allele Frequency Group (linear scale): 0.0% to 0.005%; 3.Regulatory Constraint Score (skippy); 4.Exon Normalized per Transcript (snpeff); 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.Log Odds Ratio Total (skippy); 8.All allele frequency (gnomad)
c.3988A>T	BRCA1	p.(Ser1330Cys)	0.003926	0.003935	Predicted benign = 1.Exon Length (skippy); 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Mean hSNP Regulatory Constraint Score (skippy); 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.Min Distance from a SS (skippy)
c.398G>A	BRCA1	p.(Arg133His)	0.206667	0.123584	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Allele Frequency Group (linear scale): 0.0% to 0.005%; 4.Exon Normalized per Transcript (snpeff); 5.SIFT prediction (dbnsfp): Damaging; 6.Regulatory Constraint Score (skippy); 7.Amino Acid Length (snpeff); 8.Log Odds Ratio Total (skippy)
c.4006A>T	BRCA1	p.(Ser1336Cys)	0.001049	0.000945	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Mean hSNP Regulatory Constraint Score (skippy); 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.4031A>G	BRCA1	p.(Asp1344Gly)	0.004301	0.003929	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Regulatory Constraint Score (skippy); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.4036G>A	BRCA1	p.(Glu1346Lys)	0.000167	0.000204	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.4046C>G	BRCA1	p.(Thr1349Arg)	0.004195	0.003437	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.Mean hSNP Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.4081A>T	BRCA1	p.(Met1361Leu)	0.000684	0.000472	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.4103C>T	BRCA1	p.(Ala1368Val)	0.000574	0.000534	Predicted benign = 1.GERP++NR and GERP++RS difference (dbnsfp); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.4184A>G	BRCA1	p.(Gln1395Arg)	0.910370	0.055042	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Mean hSNP Regulatory Constraint Score (skippy); 3.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 4.phastCons100way vertebrate (dbnsfp); 5.LRT prediction (dbnsfp): Deleterious; 6.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 7.Exon Normalized per Transcript (snpeff); 8.All allele frequency (gnomad)
c.4213A>G	BRCA1	p.(Ile1405Val)	0.000821	0.000706	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.4262A>G	BRCA1	p.(His1421Arg)	0.002315	0.001227	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Regulatory Constraint Score (skippy); 7.Amino Acid Length (snpeff); 8.Min Distance from a SS (skippy)
c.4288C>T	BRCA1	p.(Pro1430Ser)	0.001429	0.000910	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Regulatory Constraint Score (skippy); 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.4342A>G	BRCA1	p.(Ser1448Gly)	0.000179	0.000153	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.43A>C	BRCA1	p.(Ile15Leu)	0.002499	0.003179	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.LRT prediction (dbnsfp): Neutral; 6.SIFT prediction (dbnsfp): Tolerated; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.4484G>C	BRCA1	p.(Arg1495Thr)	0.821603	0.108819	Predicted pathogenic = 1.Has one or more PUBMEDs curated by HGMD: True; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.phastCons100way vertebrate (dbnsfp); 5.Mean hSNP Regulatory Constraint Score (skippy); 6.Exon Normalized per Transcript (snpeff); 7.Exon Length (skippy); 8.All allele frequency (gnomad)
c.4520G>C	BRCA1	p.(Arg1507Thr)	0.000321	0.000302	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.455T>C	BRCA1	p.(Leu152Pro)	0.002031	0.001064	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.SIFT prediction (dbnsfp): Damaging; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.4585A>G	BRCA1	p.(Ile1529Val)	0.000844	0.001240	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.4657T>A	BRCA1	p.(Leu1553Met)	0.021825	0.015252	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.GERP++NR and GERP++RS difference (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.4675G>A	BRCA1	p.(Glu1559Lys)	0.650609	0.185638	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has one or more PUBMEDs curated by HGMD: True; 3.HGMD-assigned category: DM; 4.Potential Splice Variant on +20/-3: True; 5.Has an entry in HGMD: True; 6.phastCons100way vertebrate (dbnsfp); 7.Exon Normalized per Transcript (snpeff); 8.Exon Length (skippy)
c.469T>C	BRCA1	p.(Ser157Pro)	0.461985	0.153003	Predicted benign = 1.LRT prediction (dbnsfp): Neutral; 2.Exon Type (skippy): internal_exon_protein_coding; 3.MutationTaster prediction (dbnsfp): Disease causing; 4.SIFT prediction (dbnsfp): Damaging; 5.Gene: BRCA1; 6.Exon Normalized per Transcript (snpeff); 7.Amino Acid Length (snpeff); 8.Regulatory Constraint Score (skippy)
c.4726G>C	BRCA1	p.(Glu1576Gln)	0.007467	0.009015	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.Regulatory Constraint Score (skippy)
c.4733A>G	BRCA1	p.(Asp1578Gly)	0.004337	0.003907	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.4766G>A	BRCA1	p.(Arg1589His)	0.000619	0.000446	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.4776C>A	BRCA1	p.(Asn1592Lys)	0.011439	0.009556	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.478G>C	BRCA1	p.(Gly160Arg)	0.338489	0.166527	Predicted benign = 1.ESE Losses (skippy); 2.Exon Type (skippy): internal_exon_protein_coding; 3.SIFT prediction (dbnsfp): Damaging; 4.Regulatory Constraint Score (skippy); 5.Gene: BRCA1; 6.Polyphen2 HVAR prediction (dbnsfp): Possibly damaging; 7.Exon Normalized per Transcript (snpeff); 8.Amino Acid Length (snpeff)
c.4814T>C	BRCA1	p.(Leu1605Ser)	0.005690	0.003719	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.phastCons100way vertebrate (dbnsfp); 6.Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.4816A>G	BRCA1	p.(Lys1606Glu)	0.096674	0.079000	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.5068A>C	BRCA1	p.(Lys1690Gln)	0.132684	0.100106	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.Regulatory Constraint Score (skippy); 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.All allele frequency (gnomad); 8.East Asian allele frequency (gnomad)
c.5078_5080del	BRCA1	p.(Ala1693del)	0.948758	0.043685	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has one or more PUBMEDs curated by HGMD: True; 3.HGMD-assigned category: DM; 4.Potential Splice Variant on +20/-3: True; 5.Has an entry in HGMD: True; 6.Exon Normalized per Transcript (snpeff); 7.Associated with cancer by HGMD: True; 8.All allele frequency (gnomad)
c.508C>T	BRCA1	p.(Arg170Trp)	0.000301	0.000254	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.5144G>A	BRCA1	p.(Ser1715Asn)	0.997989	0.002142	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.5189A>G	BRCA1	p.(Asn1730Ser)	0.000336	0.000314	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.5189A>T	BRCA1	p.(Asn1730Ile)	0.104742	0.074464	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.Exon Type (skippy): internal_exon_protein_coding; 4.SIFT prediction (dbnsfp): Damaging; 5.Amino Acid Length (snpeff); 6.Regulatory Constraint Score (skippy); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Log Odds Ratio Total (skippy)
c.5198A>G	BRCA1	p.(Asp1733Gly)	0.044310	0.041423	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.5207T>G	BRCA1	p.(Val1736Gly)	0.996187	0.003233	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.5213G>A	BRCA1	p.(Gly1738Glu)	0.996582	0.002524	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.5216A>T	BRCA1	p.(Asp1739Val)	0.821242	0.140925	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has an entry in HGMD: True; 3.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 4.phastCons100way vertebrate (dbnsfp); 5.LRT prediction (dbnsfp): Deleterious; 6.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.5243G>A	BRCA1	p.(Gly1748Asp)	0.993747	0.006386	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.5312C>G	BRCA1	p.(Pro1771Arg)	0.655637	0.132253	Predicted pathogenic = 1.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 2.phastCons100way vertebrate (dbnsfp); 3.Exon Normalized per Transcript (snpeff); 4.LRT prediction (dbnsfp): Deleterious; 5.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 6.Exon Length (skippy); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.53T>C	BRCA1	p.(Met18Thr)	0.988480	0.009381	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has one or more PUBMEDs curated by HGMD: True; 3.HGMD-assigned category: DM; 4.Has an entry in HGMD: True; 5.phastCons100way vertebrate (dbnsfp); 6.Mean hSNP Regulatory Constraint Score (skippy); 7.LRT prediction (dbnsfp): Deleterious; 8.All allele frequency (gnomad)
c.5456A>G	BRCA1	p.(Asn1819Ser)	0.000184	0.000171	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.5504G>A	BRCA1	p.(Arg1835Gln)	0.020504	0.018178	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.All allele frequency (gnomad); 8.East Asian allele frequency (gnomad)
c.5531T>G	BRCA1	p.(Leu1844Arg)	0.010160	0.010835	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.5553C>G	BRCA1	p.(Asp1851Glu)	0.009470	0.009868	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.GERP++NR and GERP++RS difference (dbnsfp)
c.716A>G	BRCA1	p.(His239Arg)	0.000275	0.000265	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.722C>T	BRCA1	p.(Pro241Leu)	0.000043	0.000045	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.792T>A	BRCA1	p.(Ser264Arg)	0.022740	0.015908	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.Regulatory Constraint Score (skippy); 5.SIFT prediction (dbnsfp): Damaging; 6.Amino Acid Length (snpeff); 7.Min Distance from a SS (skippy); 8.Log Odds Ratio Total (skippy)
c.823G>A	BRCA1	p.(Gly275Ser)	0.049729	0.068447	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Exon Length (skippy); 3.Has sample(s) where the variant co-occurred with a known P/LP: True; 4.LRT prediction (dbnsfp): Neutral; 5.Allele Frequency Group (linear scale): 0.05% to 100.0%; 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.824G>A	BRCA1	p.(Gly275Asp)	0.161106	0.117090	Predicted benign = 1.Exon Length (skippy); 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Allele Frequency Group (logscale): 0.001% to 0.01%; 4.LRT prediction (dbnsfp): Neutral; 5.Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.827C>G	BRCA1	p.(Thr276Arg)	0.511444	0.212375	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has one or more PUBMEDs curated by HGMD: True; 3.HGMD-assigned category: DM; 4.Has an entry in HGMD: True; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.phastCons100way vertebrate (dbnsfp); 7.Associated with cancer by HGMD: True; 8.LRT prediction (dbnsfp): Deleterious
c.891G>T	BRCA1	p.(Met297Ile)	0.006710	0.005657	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.Regulatory Constraint Score (skippy); 6.Min Distance from a SS (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.932C>T	BRCA1	p.(Pro311Leu)	0.001327	0.001244	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.964G>A	BRCA1	p.(Ala322Thr)	0.005785	0.007055	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Regulatory Constraint Score (skippy); 8.Amino Acid Length (snpeff)
c.964G>C	BRCA1	p.(Ala322Pro)	0.000425	0.000387	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.994C>T	BRCA1	p.(Arg332Trp)	0.002371	0.002141	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Amino Acid Length (snpeff)
c.997A>G	BRCA1	p.(Thr333Ala)	0.000028	0.000043	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.Amino Acid Length (snpeff)
c.10070C>T	BRCA2	p.(Thr3357Ile)	0.000037	0.000040	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.10120A>G	BRCA2	p.(Thr3374Ala)	0.000061	0.000064	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.10121C>T	BRCA2	p.(Thr3374Ile)	0.000000	0.000000	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.10204G>A	BRCA2	p.(Glu3402Lys)	0.000355	0.000299	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.1040A>G	BRCA2	p.(Gln347Arg)	0.000000	0.000001	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.1124C>T	BRCA2	p.(Pro375Leu)	0.000343	0.000250	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.SIFT prediction (dbnsfp): Damaging
c.1127T>G	BRCA2	p.(Phe376Cys)	0.007514	0.007575	Predicted benign = 1.LRT prediction (dbnsfp): Neutral; 2.MutationTaster prediction (dbnsfp): Polymorphism; 3.Amino Acid Length (snpeff); 4.Exon Length (skippy); 5.phastCons100way vertebrate (dbnsfp); 6.Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Exon Normalized per Transcript (snpeff)
c.1166C>A	BRCA2	p.(Pro389Gln)	0.000003	0.000004	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.116C>T	BRCA2	p.(Ala39Val)	0.452714	0.181535	Predicted benign = 1.HGMD-assigned category: DM_maybe; 2.nearestSSType (alamut): 3'; 3.Exon Type (skippy): internal_exon_protein_coding; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.Exon Normalized per Transcript (snpeff); 7.Regulatory Constraint Score (skippy); 8.SIFT prediction (dbnsfp): Damaging
c.1181A>C	BRCA2	p.(Glu394Ala)	0.000012	0.000008	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.1225G>A	BRCA2	p.(Glu409Lys)	0.000589	0.000620	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.LRT prediction (dbnsfp): Neutral; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.SIFT prediction (dbnsfp): Damaging
c.1247T>G	BRCA2	p.(Ile416Ser)	0.000108	0.000103	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.1447G>A	BRCA2	p.(Ala483Thr)	0.000065	0.000056	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.1466C>G	BRCA2	p.(Ser489Cys)	0.000931	0.000827	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Amino Acid Length (snpeff); 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.All allele frequency (gnomad); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.1514T>C	BRCA2	p.(Ile505Thr)	0.000054	0.000076	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.1786G>C	BRCA2	p.(Asp596His)	0.004455	0.006164	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Exon Normalized per Transcript (snpeff); 8.All allele frequency (gnomad)
c.1792A>G	BRCA2	p.(Thr598Ala)	0.000191	0.000465	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.All allele frequency (gnomad); 8.phastCons100way vertebrate (dbnsfp)
c.1796C>T	BRCA2	p.(Ser599Phe)	0.001164	0.001347	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.Exon Normalized per Transcript (snpeff)
c.1798T>C	BRCA2	p.(Tyr600His)	0.000000	0.000000	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.1810A>G	BRCA2	p.(Lys604Glu)	0.000072	0.000079	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.1814T>C	BRCA2	p.(Ile605Thr)	0.000222	0.000214	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.1865C>T	BRCA2	p.(Ala622Val)	0.000276	0.000231	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.1875T>A	BRCA2	p.(Phe625Leu)	0.000069	0.000046	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.1885C>T	BRCA2	p.(Leu629Phe)	0.000519	0.000437	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.phastCons100way vertebrate (dbnsfp)
c.1897A>G	BRCA2	p.(Asn633Asp)	0.000476	0.000428	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.1938C>A	BRCA2	p.(Ser646Arg)	0.000052	0.000031	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.2125C>G	BRCA2	p.(Leu709Val)	0.000022	0.000014	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.2135T>C	BRCA2	p.(Leu712Pro)	0.000014	0.000011	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.phastCons100way vertebrate (dbnsfp)
c.2213G>T	BRCA2	p.(Cys738Phe)	0.000041	0.000029	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.2303C>T	BRCA2	p.(Thr768Ile)	0.000025	0.000021	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.2330A>G	BRCA2	p.(Asp777Gly)	0.000002	0.000002	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.2348T>G	BRCA2	p.(Val783Gly)	0.000015	0.000013	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.241T>G	BRCA2	p.(Phe81Val)	0.321644	0.144034	Predicted benign = 1.Exon Type (skippy): internal_exon_protein_coding; 2.Allele Frequency Group (linear scale): 0.0% to 0.005%; 3.Amino Acid Length (snpeff); 4.Exon Normalized per Transcript (snpeff); 5.SIFT prediction (dbnsfp): Damaging; 6.Regulatory Constraint Score (skippy); 7.Log Odds Ratio Total (skippy); 8.Min Distance from a SS (skippy)
c.2429C>T	BRCA2	p.(Thr810Ile)	0.000040	0.000029	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.2515T>C	BRCA2	p.(Tyr839His)	0.000013	0.000011	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.phastCons100way vertebrate (dbnsfp)
c.2589T>A	BRCA2	p.(Asn863Lys)	0.000000	0.000000	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.2632G>C	BRCA2	p.(Asp878His)	0.000018	0.000021	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.SIFT prediction (dbnsfp): Damaging; 8.Exon Normalized per Transcript (snpeff)
c.2698A>G	BRCA2	p.(Asn900Asp)	0.000042	0.000042	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.2803G>C	BRCA2	p.(Asp935His)	0.000000	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.2872A>G	BRCA2	p.(Ser958Gly)	0.000038	0.000035	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.2920G>A	BRCA2	p.(Asp974Asn)	0.000001	0.000002	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.2963A>C	BRCA2	p.(Asp988Ala)	0.000160	0.000136	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Amino Acid Length (snpeff); 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Exon Normalized per Transcript (snpeff)
c.2987T>G	BRCA2	p.(Leu996Arg)	0.000002	0.000003	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.3071_3073del	BRCA2	p.(Ile1024del)	0.032324	0.019558	Predicted benign = 1.Exon Length (skippy); 2.nearestSSType (alamut): 3'; 3.Gene: BRCA2; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.phastCons100way vertebrate (dbnsfp); 7.Exon Normalized per Transcript (snpeff)
c.3088T>G	BRCA2	p.(Phe1030Val)	0.000003	0.000004	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.SIFT prediction (dbnsfp): Damaging
c.3172A>C	BRCA2	p.(Lys1058Gln)	0.000391	0.000437	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Exon Normalized per Transcript (snpeff); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.3197A>G	BRCA2	p.(Asn1066Ser)	0.000003	0.000004	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.322A>C	BRCA2	p.(Asn108His)	0.000002	0.000005	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.3260C>T	BRCA2	p.(Thr1087Ile)	0.000013	0.000014	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.3326C>T	BRCA2	p.(Ala1109Val)	0.017994	0.023668	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Regulatory Constraint Score (skippy); 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Exon Normalized per Transcript (snpeff); 8.All allele frequency (gnomad)
c.343A>G	BRCA2	p.(Lys115Glu)	0.001684	0.001570	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.SIFT prediction (dbnsfp): Damaging
c.3445A>G	BRCA2	p.(Met1149Val)	0.000003	0.000006	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.3503T>C	BRCA2	p.(Met1168Thr)	0.000178	0.000282	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.3569G>A	BRCA2	p.(Arg1190Gln)	0.000004	0.000007	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.3575T>G	BRCA2	p.(Phe1192Cys)	0.000002	0.000006	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.3598T>A	BRCA2	p.(Cys1200Ser)	0.000003	0.000005	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.3622T>A	BRCA2	p.(Leu1208Ile)	0.000009	0.000011	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.3731T>C	BRCA2	p.(Ile1244Thr)	0.000073	0.000125	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Exon Normalized per Transcript (snpeff); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.3749A>G	BRCA2	p.(Glu1250Gly)	0.000003	0.000006	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Allele Frequency Group (linear scale): 0.0% to 0.005%; 8.Amino Acid Length (snpeff)
c.3865A>G	BRCA2	p.(Lys1289Glu)	0.000006	0.000010	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.3962A>G	BRCA2	p.(Asp1321Gly)	0.000000	0.000001	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.3966C>G	BRCA2	p.(Asn1322Lys)	0.000004	0.000009	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.SIFT prediction (dbnsfp): Tolerated; 4.Mean hSNP Regulatory Constraint Score (skippy); 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.4141_4143del	BRCA2	p.(Lys1381del)	0.053051	0.034192	Predicted benign = 1.Exon Length (skippy); 2.nearestSSType (alamut): 3'; 3.Gene: BRCA2; 4.Amino Acid Length (snpeff); 5.phastCons100way vertebrate (dbnsfp); 6.Exon Normalized per Transcript (snpeff)
c.4146_4148del	BRCA2	p.(Glu1382del)	0.013126	0.013314	Predicted benign = 1.Exon Length (skippy); 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.nearestSSType (alamut): 3'; 4.Allele Frequency Group (linear scale): 0.005% to 0.01%; 5.Amino Acid Length (snpeff); 6.phastCons100way vertebrate (dbnsfp); 7.Exon Normalized per Transcript (snpeff); 8.All allele frequency (gnomad)
c.4159T>A	BRCA2	p.(Leu1387Ile)	0.000841	0.001459	Predicted benign = 1.Exon Length (skippy); 2.Min Distance from a SS (skippy); 3.SIFT prediction (dbnsfp): Tolerated; 4.Regulatory Constraint Score (skippy); 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.Exon Normalized per Transcript (snpeff)
c.4271C>G	BRCA2	p.(Ser1424Cys)	0.000001	0.000002	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.4334A>T	BRCA2	p.(Lys1445Ile)	0.002136	0.003931	Predicted benign = 1.Exon Length (skippy); 2.Min Distance from a SS (skippy); 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Exon Normalized per Transcript (snpeff)
c.4376A>G	BRCA2	p.(Asn1459Ser)	0.000000	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.437T>C	BRCA2	p.(Leu146Pro)	0.004236	0.004256	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.nearestSSType (alamut): 3'; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.Exon Normalized per Transcript (snpeff)
c.440A>G	BRCA2	p.(Gln147Arg)	0.000067	0.000075	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.4483G>A	BRCA2	p.(Val1495Ile)	0.000000	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.4558A>G	BRCA2	p.(Thr1520Ala)	0.000002	0.000006	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.4718G>A	BRCA2	p.(Cys1573Tyr)	0.000001	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.4779A>C	BRCA2	p.(Glu1593Asp)	0.000000	0.000000	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.4828G>A	BRCA2	p.(Val1610Met)	0.000000	0.000000	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.4849A>C	BRCA2	p.(Ser1617Arg)	0.000036	0.000054	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.4856A>G	BRCA2	p.(Asn1619Ser)	0.000007	0.000012	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.4861T>G	BRCA2	p.(Cys1621Gly)	0.000001	0.000001	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.4874A>G	BRCA2	p.(Glu1625Gly)	0.000016	0.000025	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.4901T>C	BRCA2	p.(Phe1634Ser)	0.000002	0.000004	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.4915G>A	BRCA2	p.(Val1639Ile)	0.000001	0.000002	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.4987G>C	BRCA2	p.(Val1663Leu)	0.000010	0.000015	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.5020A>G	BRCA2	p.(Ser1674Gly)	0.000000	0.000000	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.506A>G	BRCA2	p.(Lys169Arg)	0.002107	0.002288	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.5117A>C	BRCA2	p.(Asn1706Thr)	0.000029	0.000043	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.SIFT prediction (dbnsfp): Tolerated; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.5171T>C	BRCA2	p.(Ile1724Thr)	0.000010	0.000014	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.5186A>G	BRCA2	p.(Lys1729Arg)	0.000008	0.000011	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.5383A>G	BRCA2	p.(Lys1795Glu)	0.000015	0.000021	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.5474C>T	BRCA2	p.(Ala1825Val)	0.000000	0.000000	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.5507A>C	BRCA2	p.(Asn1836Thr)	0.000018	0.000019	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.5552T>G	BRCA2	p.(Ile1851Ser)	0.000002	0.000003	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.5554G>A	BRCA2	p.(Val1852Ile)	0.000001	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.All allele frequency (gnomad)
c.5602G>T	BRCA2	p.(Asp1868Tyr)	0.003280	0.003823	Predicted benign = 1.Exon Length (skippy); 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Amino Acid Length (snpeff); 5.phastCons100way vertebrate (dbnsfp); 6.SIFT prediction (dbnsfp): Damaging; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Exon Normalized per Transcript (snpeff)
c.5634C>G	BRCA2	p.(Asn1878Lys)	0.000005	0.000006	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.5635G>A	BRCA2	p.(Glu1879Lys)	0.000001	0.000001	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.5640T>G	BRCA2	p.(Asn1880Lys)	0.000000	0.000000	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.5649A>C	BRCA2	p.(Lys1883Asn)	0.000018	0.000020	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.5651T>C	BRCA2	p.(Ile1884Thr)	0.000016	0.000017	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.5702A>T	BRCA2	p.(Glu1901Val)	0.000036	0.000037	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.5723T>C	BRCA2	p.(Leu1908Pro)	0.000001	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.5753A>G	BRCA2	p.(His1918Arg)	0.000001	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.5768A>C	BRCA2	p.(Asp1923Ala)	0.000000	0.000000	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.5821A>C	BRCA2	p.(Lys1941Gln)	0.000007	0.000007	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.5969A>G	BRCA2	p.(Asp1990Gly)	0.000264	0.000272	Predicted benign = 1.Exon Length (skippy); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.Regulatory Constraint Score (skippy); 6.Amino Acid Length (snpeff); 7.SIFT prediction (dbnsfp): Damaging; 8.Exon Normalized per Transcript (snpeff)
c.6131G>C	BRCA2	p.(Gly2044Ala)	0.000000	0.000000	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.6131G>T	BRCA2	p.(Gly2044Val)	0.000075	0.000094	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.6188G>A	BRCA2	p.(Gly2063Glu)	0.016630	0.012956	Predicted benign = 1.Exon Length (skippy); 2.SIFT prediction (dbnsfp): Tolerated; 3.Min Distance from a SS (skippy); 4.Exon Type (skippy): internal_exon_protein_coding; 5.Amino Acid Length (snpeff); 6.MutationTaster prediction (dbnsfp): Disease causing; 7.Regulatory Constraint Score (skippy); 8.Exon Normalized per Transcript (snpeff)
c.6196G>A	BRCA2	p.(Val2066Ile)	0.026369	0.025519	Predicted benign = 1.Exon Length (skippy); 2.SIFT prediction (dbnsfp): Tolerated; 3.Exon Type (skippy): internal_exon_protein_coding; 4.Min Distance from a SS (skippy); 5.Mean hSNP Regulatory Constraint Score (skippy); 6.Amino Acid Length (snpeff); 7.MutationTaster prediction (dbnsfp): Disease causing; 8.Exon Normalized per Transcript (snpeff)
c.6258C>G	BRCA2	p.(Ile2086Met)	0.000001	0.000001	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.6441C>G	BRCA2	p.(His2147Gln)	0.000010	0.000009	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.6443C>A	BRCA2	p.(Ser2148Tyr)	0.000039	0.000043	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.6455C>A	BRCA2	p.(Ser2152Tyr)	0.000031	0.000027	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.6532C>T	BRCA2	p.(His2178Tyr)	0.000107	0.000100	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Mean hSNP Regulatory Constraint Score (skippy)
c.6683T>C	BRCA2	p.(Val2228Ala)	0.000005	0.000003	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.6698C>A	BRCA2	p.(Ala2233Asp)	0.027347	0.031081	Predicted benign = 1.Exon Length (skippy); 2.SIFT prediction (dbnsfp): Tolerated; 3.Allele Frequency Group (linear scale): 0.0% to 0.005%; 4.Amino Acid Length (snpeff); 5.Regulatory Constraint Score (skippy); 6.Min Distance from a SS (skippy); 7.Log Odds Ratio Total (skippy); 8.Exon Normalized per Transcript (snpeff)
c.6737C>G	BRCA2	p.(Pro2246Arg)	0.000007	0.000005	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.phastCons100way vertebrate (dbnsfp)
c.6746C>A	BRCA2	p.(Ala2249Asp)	0.000158	0.000126	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.679G>A	BRCA2	p.(Ala227Thr)	0.000697	0.000408	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Exon Normalized per Transcript (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.6871A>G	BRCA2	p.(Asn2291Asp)	0.035936	0.035269	Predicted benign = 1.LRT prediction (dbnsfp): Neutral; 2.SIFT prediction (dbnsfp): Tolerated; 3.nearestSSType (alamut): 3'; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Regulatory Constraint Score (skippy); 6.Amino Acid Length (snpeff); 7.Polyphen2 HVAR prediction (dbnsfp): Possibly damaging; 8.Exon Normalized per Transcript (snpeff)
c.6953G>A	BRCA2	p.(Arg2318Gln)	0.726998	0.123788	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has an entry in HGMD: True; 3.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 4.phastCons100way vertebrate (dbnsfp); 5.Mean hSNP Regulatory Constraint Score (skippy); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.6991A>G	BRCA2	p.(Thr2331Ala)	0.014060	0.010897	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.Exon Type (skippy): internal_exon_protein_coding; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.ESE Losses (skippy); 7.Regulatory Constraint Score (skippy); 8.SIFT prediction (dbnsfp): Damaging
c.6995G>A	BRCA2	p.(Cys2332Tyr)	0.381950	0.179299	Predicted benign = 1.ESE Losses (skippy); 2.nearestSSType (alamut): 5'; 3.Regulatory Constraint Score (skippy); 4.Exon Type (skippy): internal_exon_protein_coding; 5.Gene: BRCA2; 6.Amino Acid Length (snpeff); 7.MutationTaster prediction (dbnsfp): Disease causing; 8.SIFT prediction (dbnsfp): Damaging
c.7025A>C	BRCA2	p.(Gln2342Pro)	0.002767	0.002374	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Regulatory Constraint Score (skippy); 8.Exon Length (skippy)
c.7118G>C	BRCA2	p.(Ser2373Thr)	0.004964	0.003765	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Regulatory Constraint Score (skippy); 8.Exon Length (skippy)
c.7457A>G	BRCA2	p.(Asn2486Ser)	0.000059	0.000050	Predicted benign = 1.GERP++NR and GERP++RS difference (dbnsfp); 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.Regulatory Constraint Score (skippy)
c.7499G>C	BRCA2	p.(Arg2500Thr)	0.000201	0.000215	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.Regulatory Constraint Score (skippy)
c.7505G>A	BRCA2	p.(Arg2502His)	0.000031	0.000043	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.7512T>G	BRCA2	p.(Phe2504Leu)	0.000385	0.000299	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.phastCons100way vertebrate (dbnsfp)
c.7534C>T	BRCA2	p.(Leu2512Phe)	0.289176	0.193420	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.Regulatory Constraint Score (skippy); 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Min Distance from a SS (skippy); 8.All allele frequency (gnomad)
c.7601C>T	BRCA2	p.(Ala2534Val)	0.000195	0.000256	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.7633G>A	BRCA2	p.(Val2545Ile)	0.001458	0.001412	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Regulatory Constraint Score (skippy)
c.7783G>T	BRCA2	p.(Ala2595Ser)	0.003294	0.002741	Predicted benign = 1.LRT prediction (dbnsfp): Neutral; 2.SIFT prediction (dbnsfp): Tolerated; 3.Exon Type (skippy): internal_exon_protein_coding; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.Polyphen2 HVAR prediction (dbnsfp): Possibly damaging; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Log Odds Ratio Total (skippy)
c.7819A>C	BRCA2	p.(Thr2607Pro)	0.443117	0.196612	Predicted benign = 1.nearestSSType (alamut): 3'; 2.Exon Type (skippy): internal_exon_protein_coding; 3.Amino Acid Length (snpeff); 4.Regulatory Constraint Score (skippy); 5.MutationTaster prediction (dbnsfp): Disease causing; 6.SIFT prediction (dbnsfp): Damaging; 7.ESE Gains (skippy); 8.Log Odds Ratio Total (skippy)
c.7975A>G	BRCA2	p.(Arg2659Gly)	0.874390	0.087257	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has an entry in HGMD: True; 3.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 4.Percent of (HSF, MaxEnt, NNS, SSF) Significant (alamut); 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.7994A>G	BRCA2	p.(Asp2665Gly)	0.060238	0.065239	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.nearestSSType (alamut): 3'; 4.Amino Acid Length (snpeff); 5.Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Exon Length (skippy); 8.All allele frequency (gnomad)
c.8009C>T	BRCA2	p.(Ser2670Leu)	0.949923	0.038638	Predicted pathogenic = 1.HGMD-assigned category: DM; 2.Has an entry in HGMD: True; 3.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 4.phastCons100way vertebrate (dbnsfp); 5.LRT prediction (dbnsfp): Deleterious; 6.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.800G>A	BRCA2	p.(Gly267Glu)	0.000201	0.000207	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.8182G>A	BRCA2	p.(Val2728Ile)	0.001570	0.008150	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.8254A>T	BRCA2	p.(Ile2752Phe)	0.068731	0.061585	Predicted benign = 1.LRT prediction (dbnsfp): Neutral; 2.SIFT prediction (dbnsfp): Tolerated; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Amino Acid Length (snpeff); 5.Regulatory Constraint Score (skippy); 6.phastCons100way vertebrate (dbnsfp); 7.Min Distance from a SS (skippy); 8.Exon Length (skippy)
c.8308G>A	BRCA2	p.(Ala2770Thr)	0.994436	0.006750	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.831T>G	BRCA2	p.(Asn277Lys)	0.010031	0.016323	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.phastCons100way vertebrate (dbnsfp); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.8324T>C	BRCA2	p.(Met2775Thr)	0.020521	0.023316	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.SIFT prediction (dbnsfp): Tolerated; 3.Allele Frequency Group (linear scale): 0.005% to 0.01%; 4.Exon Type (skippy): internal_exon_protein_coding; 5.Amino Acid Length (snpeff); 6.Mean hSNP Regulatory Constraint Score (skippy); 7.Exon Length (skippy); 8.All allele frequency (gnomad)
c.8386C>T	BRCA2	p.(Pro2796Ser)	0.000083	0.000070	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.841G>A	BRCA2	p.(Asp281Asn)	0.002185	0.003276	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.8428A>G	BRCA2	p.(Ser2810Gly)	0.015733	0.015573	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.Exon Type (skippy): internal_exon_protein_coding; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Regulatory Constraint Score (skippy); 8.Min Distance from a SS (skippy)
c.8432A>G	BRCA2	p.(Asp2811Gly)	0.251521	0.154076	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.LRT prediction (dbnsfp): Neutral; 3.SIFT prediction (dbnsfp): Tolerated; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Allele Frequency Group (linear scale): 0.0% to 0.005%; 6.Amino Acid Length (snpeff); 7.Regulatory Constraint Score (skippy); 8.Min Distance from a SS (skippy)
c.8486A>G	BRCA2	p.(Gln2829Arg)	0.845183	0.108470	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.Has an entry in HGMD: True; 3.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 4.Percent of (HSF, MaxEnt, NNS, SSF) Significant (alamut); 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.8503T>C	BRCA2	p.(Ser2835Pro)	0.000000	0.000000	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.Polyphen2 HDIV prediction (dbnsfp): Benign; 5.SIFT prediction (dbnsfp): Tolerated; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.8572C>A	BRCA2	p.(Gln2858Lys)	0.049422	0.033409	Predicted benign = 1.SIFT prediction (dbnsfp): Tolerated; 2.Exon Type (skippy): internal_exon_protein_coding; 3.Gene: BRCA2; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.MutationTaster prediction (dbnsfp): Disease causing; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.Min Distance from a SS (skippy)
c.8599A>C	BRCA2	p.(Thr2867Pro)	0.003917	0.004750	Predicted benign = 1.Allele Frequency Group (logscale): 0.001% to 0.01%; 2.LRT prediction (dbnsfp): Neutral; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Amino Acid Length (snpeff); 5.SIFT prediction (dbnsfp): Damaging; 6.Mean hSNP Regulatory Constraint Score (skippy); 7.Regulatory Constraint Score (skippy); 8.All allele frequency (gnomad)
c.8651A>G	BRCA2	p.(Tyr2884Cys)	0.000842	0.000562	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.phastCons100way vertebrate (dbnsfp)
c.8734G>A	BRCA2	p.(Ala2912Thr)	0.001905	0.001843	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.SIFT prediction (dbnsfp): Tolerated; 4.GERP++NR and GERP++RS difference (dbnsfp); 5.Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.8764A>G	BRCA2	p.(Ser2922Gly)	0.936701	0.045634	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.8789A>C	BRCA2	p.(Asn2930Thr)	0.061854	0.068890	Predicted benign = 1.LRT prediction (dbnsfp): Neutral; 2.nearestSSType (alamut): 3'; 3.Allele Frequency Group (linear scale): 0.0% to 0.005%; 4.GERP++NR and GERP++RS difference (dbnsfp); 5.Amino Acid Length (snpeff); 6.Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.Polyphen2 HVAR prediction (dbnsfp): Possibly damaging
c.8918G>A	BRCA2	p.(Arg2973His)	0.153523	0.121577	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.MutationTaster prediction (dbnsfp): Polymorphism; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.Mean hSNP Regulatory Constraint Score (skippy); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.8975_9100del	BRCA2	p.(Pro2992_Thr3033del)	0.102694	0.082312	Predicted benign = 1.Exon Length (skippy); 2.nearestSSType (alamut): 5'; 3.Gene: BRCA2; 4.Amino Acid Length (snpeff); 5.phastCons100way vertebrate (dbnsfp); 6.Homopolymer Length
c.9011A>G	BRCA2	p.(Lys3004Arg)	0.000138	0.000096	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Regulatory Constraint Score (skippy); 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.9038C>T	BRCA2	p.(Thr3013Ile)	0.000025	0.000030	Predicted benign = 1.Allele Frequency Group (logscale): 0.01% to 0.1%; 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.9043A>G	BRCA2	p.(Lys3015Glu)	0.000130	0.000129	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.Regulatory Constraint Score (skippy)
c.9104A>C	BRCA2	p.(Tyr3035Ser)	0.105137	0.095749	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Allele Frequency Group (linear scale): 0.005% to 0.01%; 4.Amino Acid Length (snpeff); 5.SIFT prediction (dbnsfp): Damaging; 6.Regulatory Constraint Score (skippy); 7.Latino allele frequency (gnomad); 8.All allele frequency (gnomad)
c.9175A>G	BRCA2	p.(Lys3059Glu)	0.001087	0.000909	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Allele Frequency Group (linear scale): 0.0% to 0.005%; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.9199C>T	BRCA2	p.(Pro3067Ser)	0.015023	0.014125	Predicted benign = 1.ESE Losses (skippy); 2.Exon Type (skippy): internal_exon_protein_coding; 3.Allele Frequency Group (linear scale): 0.0% to 0.005%; 4.Amino Acid Length (snpeff); 5.Mean hSNP Regulatory Constraint Score (skippy); 6.SIFT prediction (dbnsfp): Damaging; 7.Polyphen2 HVAR prediction (dbnsfp): Possibly damaging; 8.Min Distance from a SS (skippy)
c.9242T>C	BRCA2	p.(Val3081Ala)	0.125847	0.125643	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Regulatory Constraint Score (skippy); 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.Polyphen2 HVAR prediction (dbnsfp): Possibly damaging; 8.Log Odds Ratio Total (skippy)
c.9263C>T	BRCA2	p.(Ala3088Val)	0.013875	0.010348	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.SIFT prediction (dbnsfp): Tolerated; 4.nearestSSType (alamut): 3'; 5.Exon Type (skippy): internal_exon_protein_coding; 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.Regulatory Constraint Score (skippy)
c.9286G>A	BRCA2	p.(Glu3096Lys)	0.125130	0.076353	Predicted benign = 1.ESE Losses (skippy); 2.nearestSSType (alamut): 3'; 3.Exon Type (skippy): internal_exon_protein_coding; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.MutationTaster prediction (dbnsfp): Disease causing; 7.Mean hSNP Regulatory Constraint Score (skippy); 8.SIFT prediction (dbnsfp): Damaging
c.9350A>C	BRCA2	p.(His3117Pro)	0.000457	0.000471	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Mean hSNP Regulatory Constraint Score (skippy); 6.MutationTaster prediction (dbnsfp): Polymorphism; 7.Amino Acid Length (snpeff); 8.phastCons100way vertebrate (dbnsfp)
c.9371A>T	BRCA2	p.(Asn3124Ile)	0.909987	0.068203	Predicted pathogenic = 1.Is the variant absent or at extremely low frequency (<0.01%) in control population databases (>1000 individuals / 2000 alleles tested)?: yes; 2.HGMD-assigned category: DM; 3.Has an entry in HGMD: True; 4.Polyphen2 HVAR prediction (dbnsfp): Probably damaging; 5.phastCons100way vertebrate (dbnsfp); 6.LRT prediction (dbnsfp): Deleterious; 7.Polyphen2 HDIV prediction (dbnsfp): Probably damaging; 8.All allele frequency (gnomad)
c.9434T>C	BRCA2	p.(Val3145Ala)	0.000603	0.000416	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.Mean hSNP Regulatory Constraint Score (skippy); 8.phastCons100way vertebrate (dbnsfp)
c.9458G>C	BRCA2	p.(Gly3153Ala)	0.000073	0.000091	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.9500A>C	BRCA2	p.(Glu3167Ala)	0.035120	0.029965	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.Polyphen2 HDIV prediction (dbnsfp): Benign; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.Regulatory Constraint Score (skippy); 6.Exon Type (skippy): internal_exon_protein_coding; 7.Amino Acid Length (snpeff); 8.Homopolymer Length
c.9513_9515del	BRCA2	p.(Leu3172del)	0.076277	0.053464	Predicted benign = 1.Exon Length (skippy); 2.nearestSSType (alamut): 3'; 3.Gene: BRCA2; 4.Amino Acid Length (snpeff); 5.phastCons100way vertebrate (dbnsfp)
c.955A>G	BRCA2	p.(Asn319Asp)	0.000667	0.000698	Predicted benign = 1.Polyphen2 HVAR prediction (dbnsfp): Benign; 2.LRT prediction (dbnsfp): Neutral; 3.SIFT prediction (dbnsfp): Tolerated; 4.MutationTaster prediction (dbnsfp): Polymorphism; 5.Amino Acid Length (snpeff); 6.Exon Length (skippy); 7.phastCons100way vertebrate (dbnsfp); 8.Exon Normalized per Transcript (snpeff)
c.956A>G	BRCA2	p.(Asn319Ser)	0.000153	0.000136	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Polyphen2 HVAR prediction (dbnsfp): Benign; 3.Polyphen2 HDIV prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.9581C>A	BRCA2	p.(Pro3194Gln)	0.006701	0.005856	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.LRT prediction (dbnsfp): Neutral; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
c.964A>C	BRCA2	p.(Lys322Gln)	0.020361	0.025029	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.LRT prediction (dbnsfp): Neutral; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.SIFT prediction (dbnsfp): Damaging; 8.All allele frequency (gnomad)
c.9875C>T	BRCA2	p.(Pro3292Leu)	0.024103	0.028972	Predicted benign = 1.Exon Length (skippy); 2.Has sample(s) where the variant co-occurred with a known P/LP: True; 3.Allele Frequency Group (logscale): 0.001% to 0.01%; 4.nearestSSType (alamut): 3'; 5.Amino Acid Length (snpeff); 6.SIFT prediction (dbnsfp): Damaging; 7.All allele frequency (gnomad); 8.East Asian allele frequency (gnomad)
c.9905G>A	BRCA2	p.(Arg3302Lys)	0.180518	0.120299	Predicted benign = 1.Exon Length (skippy); 2.nearestSSType (alamut): 3'; 3.Gene: BRCA2; 4.Allele Frequency Group (linear scale): 0.0% to 0.005%; 5.Amino Acid Length (snpeff); 6.MutationTaster prediction (dbnsfp): Disease causing; 7.SIFT prediction (dbnsfp): Damaging
c.9925G>A	BRCA2	p.(Glu3309Lys)	0.000014	0.000024	Predicted benign = 1.Has sample(s) where the variant co-occurred with a known P/LP: True; 2.Allele Frequency Group (logscale): 0.001% to 0.01%; 3.Polyphen2 HVAR prediction (dbnsfp): Benign; 4.SIFT prediction (dbnsfp): Tolerated; 5.MutationTaster prediction (dbnsfp): Polymorphism; 6.Amino Acid Length (snpeff); 7.phastCons100way vertebrate (dbnsfp); 8.All allele frequency (gnomad)
